LIFR and breast carcinoma: LIFr was recently identified as a significant prognostic factor in human breast carcinoma [24], and blockade of LIFr inhibits the chemotaxis of rhabdomyosarcoma cells [13], suggesting that LIFr activation may promote metastasis and increase the invasive potential of solid tumors.